02 — Axinix
Advanced renalcell carcinoma
Who Axinix is for — and where it sits in the treatment of kidney cancer.
Approved indication
Axitinib is indicated for the treatment of advanced Renal Cell Carcinoma (RCC) after failure of one prior systemic therapy.
Where Axinixfits in treatment
-
01
Advanced RCC diagnosed
Renal cell carcinoma that has progressed beyond what surgery alone can treat.
-
02
One prior systemic therapy
The patient has received one prior systemic treatment, which has failed.
-
03
Axinix
Axitinib 5 mg twice daily as the next line of targeted therapy.